Stock Taper 
QUCY
$1.40
▲ UP 2.94% (0.04)
KEY STATISTICS
Market Cap$31.87 M
52w High$4.88
52w Low$0.30
Dividend Yield—
Frequency—
P/E-0.06
Volume162.51K
Shares Out.9.06M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
David Elliot Lazar
ABOUT
SECTOR
Healthcare
WENT PUBLIC
November 5, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
13
SPLIT RECORD
| DATE | TYPE | RATIO |
|---|---|---|
| 2024-12-03 | Reverse | 1:40 |
PRICE
$1.40 ▲ UP 2.94% (+$0.04)About Quantum Cyber N.V.
https://quantum-cyber.ai ↗Mainz Biomed NV is a Germany-based molecular genetics cancer diagnostic company developing and commercializing market-ready genetic tests for life-threatening conditions worldwide.
INDUSTRY
Medical - Diagnostics & Research
A PRODUCT QUANTUM CYBER N.V. IS KNOWN FOR
ColoAlert
ColoAlert is a non-invasive, easy-to-use at-home test for early colorectal cancer detection, marketed in Europe and seeking FDA approval for the U.S., serving as Mainz Biomed's flagship product.
RATINGS SNAPSHOT
Overall rating: C
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book3
Overall Score2
INSIDER TRADES
★
OFFICER: CHIEF FINANCIAL OFFICER
Caragol William J
Purchase · 212.5K shares
2026-08-11
★
DIRECTOR, 10 PERCENT OWNER, OFFICER: CHIEF EXECUTIVE OFFICER
Lazar David E.
Sale · 1.0M shares
2026-08-05
★
DIRECTOR, 10 PERCENT OWNER, OFFICER: CHIEF EXECUTIVE OFFICER
Lazar David E.
Sale · 1.0M shares
2026-08-05
★
DIRECTOR, 10 PERCENT OWNER, OFFICER: CHIEF EXECUTIVE OFFICER
Lazar David E.
Purchase · 28.1M shares
2026-08-05